EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank

Manrong Xu, Menghan Li, Yawen Zhang, Lianxi Li iD, Yun Shen iD, Gang Hu iD

Diabetes, Obesity and Metabolism · 2025-09 · 27 (9) · 5291-5301

DOI: 10.1111/dom.16582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 02.07.2025. Verfasst von Manrong Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: Neoplasms, Obesity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lake Health & Louisiana State University, National Natural Science Foundation of China, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The definition of clinical obesity was newly announced. Our study aims to investigate the relationship between different states of obesity and dysfunctions due to obesity with cancer incidence and mortality.

Methods

The prospective cohort study from the UK Biobank included 220 016 participants. Anthropometric parameters, in combination with obesity‐induced dysfunctions, were used to diagnose clinical obesity. Six clusters were categorized according to individual's baseline and follow‐up dysfunction status. Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for cancer incidence risk were estimated using the landmark analysis.

Results

After a mean follow‐up period of 11.0 years, a total of 24 066 cancer incidence was observed. Using Cluster 1 (participants without obesity and dysfunction at baseline and during follow‐up) as the reference group, Cluster 5 (preclinical obesity with follow‐up dysfunctions; HR = 3.17, 95% CI: 3.05–3.29) exhibited the highest multivariable‐adjusted cancer incidence risk, while Cluster 4 (preclinical obesity without follow‐up dysfunctions; HR = 0.88, 95% CI: 0.85–0.92) showed the lowest. Additionally, the fully adjusted HRs for cancer mortality showed the highest in Cluster 6 (clinical obesity; HR = 1.82, 95% CI: 1.65–2.00), compared with Cluster 1. Site‐specific analyses showed consistently higher cancer risks in Cluster 5 and 6 across various types of cancer, notably the incidence of pancreatic cancer and the mortality of prostate or bladder cancer.

Conclusion

Obesity‐induced dysfunction was significantly associated with cancer risk. For future clinical practice, the early identification and intervention of clinical obesity and obesity‐induced dysfunctions are of critical importance for reducing cancer risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsObesityHumansMaleUnited KingdomFemaleMiddle AgedLongitudinal StudiesPhenotypeIncidenceProspective StudiesBiological Specimen BanksRisk FactorsAgedAdultBody Mass IndexUK Biobank

Stichwörter der Autor:innen

UK biobankcancer incidencecancer mortalityclinical obesityobesity‐induced dysfunctions

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai K…
  • Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

ORCID-Profile: Lianxi Li, Yun Shen, Gang Hu

Förderung

  • Lake Health & Louisiana State University
  • National Natural Science Foundation of China
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Xu, M., Li, M., Zhang, Y., Li, L., Shen, Y., & Hu, G. (2025). Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank. Diabetes, Obesity and Metabolism, 27(9), 5291-5301. https://doi.org/10.1111/dom.16582

Vancouver

Xu M, Li M, Zhang Y, Li L, Shen Y, Hu G. Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank. Diabetes, Obesity and Metabolism. 2025;27(9):5291-5301. doi:10.1111/dom.16582

BibTeX
@article{Xu2025,
  author = {Xu, Manrong and Li, Menghan and Zhang, Yawen and Li, Lianxi and Shen, Yun and Hu, Gang},
  title = {Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {9},
  pages = {5291--5301},
  doi = {10.1111/dom.16582}
}
Kostenlos starten →